BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21646305)

  • 1. Cortactin and focal adhesion kinase as predictors of cancer risk in patients with laryngeal premalignancy.
    Rodrigo JP; Álvarez-Alija G; Menéndez ST; Mancebo G; Allonca E; García-Carracedo D; Fresno MF; Suárez C; García-Pedrero JM
    Cancer Prev Res (Phila); 2011 Aug; 4(8):1333-41. PubMed ID: 21646305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical Expression of Cortactin and Focal Adhesion Kinase Predicts Recurrence Risk and Laryngeal Cancer Risk Beyond Histologic Grading.
    Villaronga MÁ; Hermida-Prado F; Granda-Díaz R; Menéndez ST; Álvarez-Teijeiro S; Quer M; Vilaseca I; Allonca E; Garzón-Arango M; Sanz-Moreno V; Astudillo A; Rodrigo JP; García-Pedrero JM
    Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):805-813. PubMed ID: 29654156
    [No Abstract]   [Full Text] [Related]  

  • 3. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortactin and focal adhesion kinase as predictors of cancer risk in patients with premalignant oral epithelial lesions.
    de Vicente JC; Rodrigo JP; Rodriguez-Santamarta T; Lequerica-Fernández P; Allonca E; García-Pedrero JM
    Oral Oncol; 2012 Jul; 48(7):641-6. PubMed ID: 22377015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortactin is associated with perineural invasion in the deep invasive front area of laryngeal carcinomas.
    Ambrosio EP; Rosa FE; Domingues MA; Villacis RA; Coudry Rde A; Tagliarini JV; Soares FA; Kowalski LP; Rogatto SR
    Hum Pathol; 2011 Sep; 42(9):1221-9. PubMed ID: 21419472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal adhesion kinase (FAK) immunocytochemical expression in breast ductal invasive carcinoma (DIC): correlation with clinicopathological parameters and tumor proliferative capacity.
    Theocharis SE; Klijanienko JT; Padoy E; Athanassiou S; Sastre-Garau XX
    Med Sci Monit; 2009 Aug; 15(8):BR221-6. PubMed ID: 19644410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.
    Canel M; Secades P; Rodrigo JP; Cabanillas R; Herrero A; Suarez C; Chiara MD
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3272-9. PubMed ID: 16740747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
    Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
    J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
    Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
    Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined expression of the non-receptor protein tyrosine kinases FAK and Src in primary colorectal cancer is associated with tumor recurrence and metastasis formation.
    de Heer P; Koudijs MM; van de Velde CJ; Aalbers RI; Tollenaar RA; Putter H; Morreau J; van de Water B; Kuppen PJ
    Eur J Surg Oncol; 2008 Nov; 34(11):1253-61. PubMed ID: 18556171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal adhesion kinase and E-cadherin as markers for nodal metastasis in laryngeal cancer.
    Rodrigo JP; Dominguez F; Suárez V; Canel M; Secades P; Chiara MD
    Arch Otolaryngol Head Neck Surg; 2007 Feb; 133(2):145-50. PubMed ID: 17309983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
    Madan R; Smolkin MB; Cocker R; Fayyad R; Oktay MH
    Hum Pathol; 2006 Jan; 37(1):9-15. PubMed ID: 16360410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in human gliomas is associated with unfavorable overall survival.
    Ding L; Sun X; You Y; Liu N; Fu Z
    Transl Res; 2010 Jul; 156(1):45-52. PubMed ID: 20621036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Focal adhesion kinase expression and angiogenesis in breast carcinoma].
    Huang YD; Zhang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1370-3. PubMed ID: 17884781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival.
    Folio C; Zalacain M; Zandueta C; Ormazábal C; Sierrasesúmaga L; San Julián M; de las Rivas J; Toledo G; Lecanda F; Patiño-García A
    Cancer Biomark; 2011-2012; 10(1):35-41. PubMed ID: 22297550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of focal adhesion kinase in intrahepatic cholangiocarcinoma is associated with poor tumor differentiation.
    Ohta R; Yamashita Y; Taketomi A; Kitagawa D; Kuroda Y; Itoh S; Aishima S; Maehara Y
    Oncology; 2006; 71(5-6):417-22. PubMed ID: 17687194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of focal adhesion kinase in non-small cell lung cancer.
    Carelli S; Zadra G; Vaira V; Falleni M; Bottiglieri L; Nosotti M; Di Giulio AM; Gorio A; Bosari S
    Lung Cancer; 2006 Sep; 53(3):263-71. PubMed ID: 16842883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weak expression of focal adhesion kinase (pp125FAK) in patients with cervical cancer is associated with poor disease outcome.
    Gabriel B; zur Hausen A; Stickeler E; Dietz C; Gitsch G; Fischer DC; Bouda J; Tempfer C; Hasenburg A
    Clin Cancer Res; 2006 Apr; 12(8):2476-83. PubMed ID: 16638855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal adhesion kinase: a potential target in cancer therapy.
    van Nimwegen MJ; van de Water B
    Biochem Pharmacol; 2007 Mar; 73(5):597-609. PubMed ID: 16997283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
    Kawaguchi H; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim E; Hong WK; Lippman SM; Mao L
    J Clin Oncol; 2008 Jan; 26(3):354-60. PubMed ID: 18202409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.